Green Plains and Novozymes partner in production of protein ingredients

USA – Diversified commodity-processing company, Green Plains has entered into an exclusive partnership with Danish company, Novozymes for biological solutions in the production of high protein ingredients. The partnership will be aimed at aquaculture, pet food, as well as novel ingredients to be used in the global protein markets. The collaboration will utilize the biorefinery footprint, process know-how, and global distribution capabilities of Green Plains together with Novozymes’ expertise in microbiology to create a diverse range of value-added products resulting in functional proteins. Novozymes will combine its biological solutions with…

Read More

Novozymes unveils new enzymatic toolbox for development of oat drinks

DENMARK – Novozymes has developed a new toolbox to help guide producers on expanding their businesses into the oat drinks market while enabling them to tap into the growing oat drinks markets. With the new tool, the Danish biotechnology company is banking on this growth to help dairies and beverage producers accelerate product development. According to a Nielsen report, half a billion people worldwide are either vegan or vegetarian, 26% of millennials have already embraced this lifestyle and 73% among them are willing to pay more for sustainable food and…

Read More

Novozymes makes organizational changes to deliver on growth strategy

DENMARK – The biological solutions company, Novozymes has announced some organizational changes that will include loss of upto 330 jobs worldwide, as it aims at delivering strong growth. Aligned with the strategy, announced in June this year, the company said that the updated strategic change will make resources available to investment in new growth opportunities, industries and markets, the company said. The biological solutions firm confirmed that between 280 and 330 employees will be laid off globally, of which 123 are in Denmark. “Layoffs will happen across divisions, functions and…

Read More

Court rules in favor of DuPont in Danisco patent ownership case

DENMARK – The Danish Maritime and Commercial Court has confirmed DuPont’s ownership of two amylase patent applications in Novozyme’s entitlement litigation. The Danish Court ruled in favor of Danisco’s ownership of the innovation behind two Danisco amylase patent applications (EP2859097 and EP2825643). The court reasoned that Novozymes’ legal argument that an entitlement action could be based on prior art was without merit and awarded costs to Danisco. “Testimony from the trial clearly showed that the inventions claimed in these patent applications were based on Danisco technology and reflect our long…

Read More

Denmark based biotech company Novozymes opens regional office in Kenya

KENYA – Novozymes, a Denmark based global biotechnology company, has opened a regional office in Nairobi, Kenya as it seeks to broaden its presence in East Africa. Novozymes is a global market leader in biological solutions, producing industrial enzymes and microorganisms to food and beverage industry among other sectors. The regional office will initially supply solutions to the brewing and baking industry and allow the company to meet customer and consumer needs. Thomas Steenbech Bomhoff, Novozymes’ Household Care division regional vice president said: “We are excited to invest in Kenya…

Read More

Novozymes invites collaboration on global challenges

DENMARK – Novozymes, the world leader in biological solutions, has launched HelloScience, an online network where innovators, start-ups, companies and others can collectively work to develop solutions for some of the world’s greatest challenges. HelloScience aims to foster collaborations across borders, expertise and technologies on serious global challenges, as complex problems require advanced solutions and new ways of getting solutions. “The major global challenges are complex in nature and will be difficult to solve,” says Senior Vice President Claus Crone Fuglsang, Head of Research & Technology at Novozymes. “Novozymes has…

Read More